Advertisement
Screener

IMMUNITYBIO, INC. (IBRX) Available-for-sale Securities, Amortized Cost Basis

2.8 / 5 stars · 68/120 Roast Me

IMMUNITYBIO, INC. Available-for-sale Securities, Amortized Cost Basis

IMMUNITYBIO, INC. (IBRX) had Available-for-sale Securities, Amortized Cost Basis of $0 as of 2019-03-31, per its 10-Q filed 2019-05-08.

Discontinued › Notes › Investments

us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2019-05-08

  • 2019-03-31: Available-for-sale Securities, Amortized Cost Basis $0.00.
  • 2018-12-31: Available-for-sale Securities, Amortized Cost Basis $0.00.
  • 2018-06-30: Available-for-sale Securities, Amortized Cost Basis $102.21M.
  • 2018-03-31: Available-for-sale Securities, Amortized Cost Basis $126.24M.
Period endAvailable-for-sale Securities, Amortized Cost Basis
2019-03-31$0.00
10-Q · filed 2019-05-08
2018-12-31$0.00
10-Q · filed 2019-05-08
2018-06-30$102.21M
10-Q · filed 2018-08-06
2018-03-31$126.24M
10-Q · filed 2018-05-07
2017-12-31$137.76M
10-K · filed 2019-03-13
2017-09-30$165.72M
10-Q · filed 2017-11-07
2017-06-30$197.72M
10-Q · filed 2017-08-07
2017-03-31$249.07M
10-Q · filed 2017-05-08
2016-12-31$280.70M
10-K · filed 2018-03-12
2016-09-30$288.66M
10-Q · filed 2016-11-10
2016-06-30$282.69M
10-Q · filed 2016-08-15
2016-03-31$299.10M
10-Q · filed 2016-05-16
2015-12-31$191.68M
10-K · filed 2017-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
REPLIGEN CORP (RGEN)United States$10.755B185.31
Immunovant, Inc. (IMVT)United States$7.028B-14.78
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
CG Oncology, Inc. (CGON)United States$6.095B-27.95
Scholar Rock Holding Corp (SRRK)United States$5.920B-16.37
CRISPR Therapeutics AG (CRSP)$5.390B-11.68